Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clenbuterol for Skeletal Muscle Glucose Uptake in Obesity
NCT04921306Phase 2Completed
- Sponsor
- Maastricht University
- Start
- Aug 2022
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of clenbuterol in obesity (2 arms), sponsored by Maastricht University. Primary endpoint: insulin-stimulated fluorodeoxyglucose (18F-FDG) uptake in quadriceps muscle at 4 weeks. Started Aug 2022; status: completed.
02
Drugs
clenbuterol
03
Conditions
obesity
Beyond the preview
Go deeper on NCT04921306.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04921306.